基本信息
浏览量:175
职业迁徙
个人简介
For patients with early recurrent disease defined by a rising PSA after surgery or radiation (often called biochemical recurrence) the focus of Dr. Madan's research program is to extend this potentially indolent phase with out suppressing systemic testosterone levels. Dr. Madan has explored multiple immune strategies, anti-androgen strategies without androgen deprivation, and radiopharmaceuticals in this setting. The emphasis of the trials in this setting is to delay the need for androgen suppression, while maintaining quality of life with treatments that are associated with minimal if any toxicity.
研究兴趣
论文共 384 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of clinical oncology (2024)
EUROPEAN UROLOGY ONCOLOGYno. 4 (2024): 735-741
Oncotargetno. 1 (2024): 288-300
European urology oncologyno. 5 (2024): 971-972
TRANSLATIONAL CANCER RESEARCHno. 1 (2024): 11-14
Current opinion in oncologyno. 3 (2024): 164-168
The oncologistno. 3 (2024): 185-189
JOURNAL OF CLINICAL ONCOLOGYno. 19 (2024)
Nature Reviews Urologypp.1-3, (2024)
加载更多
作者统计
#Papers: 384
#Citation: 7568
H-Index: 42
G-Index: 77
Sociability: 7
Diversity: 3
Activity: 127
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn